COVID-19 vaccines show moderate success in preventing long COVID in kids

Study reveals that COVID-19 vaccines moderately reduce the risk of long COVID in children, with higher effectiveness observed in adolescents compared to younger children.

Blockbuster cancer drug Calquence hits primary endpoint in trial for first-line mantle cell lymphoma

AstraZeneca is working on moving its BTK inhibitor Calquence into earlier stages of mantle cell lymphoma, releasing what it calls positive interim results from a

May 3, 2024

Female surgeons have lower rates of long-term adverse outcomes than their male peers, study finds

A new study published Wednesday in JAMA Surgery suggests that patients treated by female surgeons have lower rates of adverse postoperative long-term outcomes including death

August 30, 2023

Biomaterial Technology Breakthrough: Addressing Immune Response Complications in Orthopedics

Derrick Johns – CEO of DiFusion Technologies The last time we saw any meaningful advance in the development of biomaterial technology used in orthopedic implants,

November 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.